SCHEMBL6352341

SCHEMBL6352341

Cc1ccc(C(=O)Nc2ccc(Br)cc2C(=O)O)cc1S(=O)(=O)N1CCN(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
CNR2 P34972 2/20 0.51
MAPT P10636 6/20 0.50
MEN1 O00255 1/20 0.50
GBA1 P04062 1/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.50
SMPD1 P17405 1/20 0.50
KMT2A Q03164 1/20 0.50
ALB P02768 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
LMNA P02545 2/20 0.47
HSD17B10 Q99714 2/20 0.46
NPC1 O15118 1/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 1/20 0.46
PPARG P37231 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6353827 0.93 ALB (0.52) TP53SMN1; SMN2MAPTMEN1GBA1
SCHEMBL6356455 0.90 HSD17B10 (0.58) TP53SMN1; SMN2MAPTMEN1POLB
SCHEMBL6352316 0.87 ALB (0.67) TP53SMN1; SMN2ALBLMNAHTT
SCHEMBL6357053 0.87 ALB (0.51) MAPTMEN1POLBGAAKMT2A
SCHEMBL6834058 0.85 MAPT (0.49) TP53SMN1; SMN2MAPTMEN1GBA1
SCHEMBL6830625 0.85 MAPT (0.48) TP53SMN1; SMN2MAPTMEN1GBA1
SCHEMBL6833566 0.83 MAPT (0.51) SMN1; SMN2MAPTMEN1KMT2AALB
SCHEMBL6358680 0.82 ALB (0.52) MAPTMEN1POLBGAAKMT2A
SCHEMBL6352236 0.76 PPARG (0.58) TP53SMN1; SMN2ALBLMNAHTT
SCHEMBL6347825 0.75 AKR1C2 (0.70) MAPTMEN1GAAKMT2AALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 TP53 2308/4885SMN1; SMN2 3015/4885CNR2 4782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.